| 000 | 01783 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513091457.0 | ||
| 264 | 0 | _c19960801 | |
| 008 | 199608s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/0959-8049(95)00403-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGridelli, C | |
| 245 | 0 | 0 |
_aPhase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cDec 1995 |
||
| 300 |
_a2424-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Small Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCarmustine _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aEpirubicin _xadministration & dosage |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aPerrone, F | |
| 700 | 1 | _aD'Aprile, M | |
| 700 | 1 | _aRossi, A | |
| 700 | 1 | _aPalmeri, S | |
| 700 | 1 | _aCurcio, C | |
| 700 | 1 | _aVeltri, E | |
| 700 | 1 | _aIanniello, G | |
| 700 | 1 | _aLorusso, V | |
| 700 | 1 | _aPalmieri, G | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 31A _gno. 13-14 _gp. 2424-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0959-8049(95)00403-3 _zAvailable from publisher's website |
| 999 |
_c8651324 _d8651324 |
||